Araştırma Makalesi

Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation

Cilt: 8 Sayı: 3 6 Eylül 2023
PDF İndir
EN TR

Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation

Öz

Objective: Atrial fibrillation is a common cardiac arrhythmia and is an important risk factor for ischemic stroke and heart failure. Thyroid hormones have important effects on the cardiovascular system. In this study, we aimed to evaluate the relationship between atrial fibrillation (AF) and thyroid disorders. Materials and Methods: 587 newly diagnosed AF patients who applied to the Cardiology Clinic between January and December 2022 were included in this study. Thyroid function tests of the patients were examined. Results: The mean age of the patients included in the study was 62.2 ± 9.8 years. 62% of the patients were female, and 38% were male. Euthyroid in 539 patients (91.7%), hypothyroidism in 2 patients (0.3%), subclinical hypothyroidism in 11 patients (2%), hyperthyroidism in 23 patients (3.9%), and subclinical hyperthyroidism in 12 patients (2.1%). Conclusion: Atrial Fibrillation is associated with both hyperthyroidism and hypothyroidism. Thyroid dysfunctions are more common in patients with AF than in the normal population. Patients with AF should be screened for thyroid disorders.

Anahtar Kelimeler

Destekleyen Kurum

YOK

Proje Numarası

YOK

Teşekkür

YOK

Kaynakça

  1. Sagris M, Vardas EP, Theofilis P, et al. Atrial fibrillation: Pathogenesis, predisposing factors, and genetics. International Journal of Molecular Sciences. 2021;23(1):6. doi:10.3390/ijms23010006
  2. Kornej J, Börschel CS, Benjamin EJ, et al. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circulation Research. 2020;127(1):4-20. doi:10.1161/CIRCRESAHA.120.316340
  3. Sepehri Shamloo A, Dagres N, Hindricks G, et al. 2020 ESC guidelines on atrial fibrillation: Summary of the most relevant recommendations and innovations. Each Z. 2021;46:28-37. doi:10.1007/s00059-020-05005-y
  4. Kuś A, Teumer A, Medici M, et al. A deeper understanding of the causal relationships between thyroid function and atrial fibrillation. The Journal of Clinical Endocrinology & Metabolism. 2022;107(1):e429-e431. doi:10.1210/clinem/dgab525
  5. Al-Makhamreh H, Al-Ani A, Alkhulaifat D, et al. Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry. Annals of Medicine and Surgery. 2022;74:103325. doi:10.1016/j.amsu.2022.103325
  6. Huang M, Yang S, Ge G, et al. Effects of thyroid dysfunction and thyroid stimulating hormone levels on the Atrial fibrillation risks: a systematic review and dose-response meta-analysis from cohort studies. Endocrine Practice. 2022. doi:10.1016/j.eprac.2022.05.008
  7. Thyroid Diseases Diagnosis and Treatment Guide 2020. Turkish Society of Endocrinology and Metabolism https://file.temd.org.tr/Uploads/publications/guides/documents/20200929134733-2020tbl_kilavuzf527c34496.pdf?a=1. Accessed January 08, 2023.
  8. Cooper DS, Biondi B. Subclinical thyroid disease. The Lancet. 2012;379(9821): 1142-1154. doi:10.1016/S0140-6736(11)60276-6

Ayrıntılar

Birincil Dil

İngilizce

Konular

Endokrinoloji

Bölüm

Araştırma Makalesi

Erken Görünüm Tarihi

30 Ağustos 2023

Yayımlanma Tarihi

6 Eylül 2023

Gönderilme Tarihi

24 Mart 2023

Kabul Tarihi

17 Haziran 2023

Yayımlandığı Sayı

Yıl 2023 Cilt: 8 Sayı: 3

Kaynak Göster

APA
Varım, P., & Demirci, T. (2023). Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation. Online Turkish Journal of Health Sciences, 8(3), 345-349. https://doi.org/10.26453/otjhs.1270244
AMA
1.Varım P, Demirci T. Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation. OTSBD. 2023;8(3):345-349. doi:10.26453/otjhs.1270244
Chicago
Varım, Perihan, ve Taner Demirci. 2023. “Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation”. Online Turkish Journal of Health Sciences 8 (3): 345-49. https://doi.org/10.26453/otjhs.1270244.
EndNote
Varım P, Demirci T (01 Eylül 2023) Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation. Online Turkish Journal of Health Sciences 8 3 345–349.
IEEE
[1]P. Varım ve T. Demirci, “Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation”, OTSBD, c. 8, sy 3, ss. 345–349, Eyl. 2023, doi: 10.26453/otjhs.1270244.
ISNAD
Varım, Perihan - Demirci, Taner. “Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation”. Online Turkish Journal of Health Sciences 8/3 (01 Eylül 2023): 345-349. https://doi.org/10.26453/otjhs.1270244.
JAMA
1.Varım P, Demirci T. Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation. OTSBD. 2023;8:345–349.
MLA
Varım, Perihan, ve Taner Demirci. “Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation”. Online Turkish Journal of Health Sciences, c. 8, sy 3, Eylül 2023, ss. 345-9, doi:10.26453/otjhs.1270244.
Vancouver
1.Perihan Varım, Taner Demirci. Evaluation of Thyroid Dysfunction in Patients with Atrial Fibrillation. OTSBD. 01 Eylül 2023;8(3):345-9. doi:10.26453/otjhs.1270244

Cited By

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya derginin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.